NANoREG D5.07 SOP 19 Whole blood cell assay for cytokine production Acesse: https://www.rivm.nl/documenten/nanoreg-d507-sop-19-whole-blood-cell-assay-for-cytokine-production
NANoREG D5.07 SOP 19 Whole blood cell assay for cytokine production
https://www.rivm.nl/documenten/nanoreg-d507-sop-19-whole-blood-cell-assay-for-cytokine-production
NANoREG D5.07 SOP 07 HEL17T010 Colony forming efficiency assay
https://www.rivm.nl/documenten/nanoreg-d507-sop-07-hel17t010-colony-forming-efficiency-assay
NANoREG D5.07 SOP 14 Micronucleus Assay
https://www.rivm.nl/documenten/nanoreg-d507-sop-14-micronucleus-assay
NANoREG D5 08 DR Decision tree for risk assessment of MNMs
https://www.rivm.nl/en/documenten/nanoreg-d5-08-dr-decision-tree-for-risk-assessment-of-mnms
RIVM FlowChart NANoREG nanospecific risk assessment strategy
NANoREG D6 06 DR A first attempt to link physicochemical properties to functionalities as a contribution to a Decision tree strategy for the Safe by Design of MNMs
NANoREG D5.07 SOP 08 Cytotoxicity by MTS – reference to NanoValid protocol
NANoREG D2.12 DR Framework and procedures for characterization and reporting of manufactured nanomaterials for regulatory use
